Exousia Bio (LMMY) Gross Profit (2023 - 2026)

Exousia Bio (LMMY) has 4 years of Gross Profit data on file, last reported at -$62108.0 in Q1 2026.

• Quarterly Gross Profit changed N/A year-over-year to -$62108.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was -$131467.0 (down 5966.77% YoY) and the FY2025 annual result came in at -$3501.0, down 291.0% from the prior year.
• Gross Profit was little changed at -$62108.0 in Q1 2026 per LMMY's latest filing, from -$62108.0 in the prior quarter.
• The five-year high for Gross Profit was $3875.0 in Q4 2023, with the low at -$62108.0 in Q4 2025.
• Average Gross Profit over 4 years is -$17983.4, with a median of -$5917.0 recorded in 2024.
• The widest YoY moves for Gross Profit: up 22.55% in 2025, down 22.55% in 2025.
• Exousia Bio's Gross Profit stood at $3875.0 in 2023, then declined by 3.23% to $3750.0 in 2024, then tumbled by 1756.21% to -$62108.0 in 2025, then changed by 0.0% to -$62108.0 in 2026.
• Business Quant data shows LMMY's Gross Profit at -$62108.0 in Q1 2026, -$62108.0 in Q4 2025, and -$7251.0 in Q2 2025.